Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
Estimated
~$10 – $6,250
St. Jude Children's Research HospitalNCT06239272
Phase 1
Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors
Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced t…
NeuroblastomaRhabdomyosarcomaSynovial Sarcoma+11 more
Estimated
~$10 – $6,250
University of FloridaNCT06625190
Phase 1
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells gene…
Pediatric Solid TumorOsteosarcomaRhabdomyosarcoma+13 more
Estimated
~$10 – $6,250
St. Jude Children's Research HospitalNCT04897321
Phase 2
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
This is a multi-center, open label, phase II study of tebentafusp in patients with unresectable or metastatic clear cell sarcoma (CCS).
HLA-A*0201 Positive Cells PresentClear Cell Sarcoma (CCS)
Estimated
~$10 – $7,500
Sarcoma Alliance for Research through CollaborationNCT06942442